Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, Ontario. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.
Follow-Up Questions
¿Cuál es el ratio P/E de Wellbeing Digital Sciences Inc (KONEF)?
El ratio P/E de Wellbeing Digital Sciences Inc es 0
¿Quién es el CEO de Wellbeing Digital Sciences Inc?
Ms. Najla Guthrie es el Chief Executive Officer de Wellbeing Digital Sciences Inc, se unió a la empresa desde 2021.
¿Qué tal es el rendimiento del precio de la acción KONEF?
El precio actual de KONEF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Wellbeing Digital Sciences Inc?
Wellbeing Digital Sciences Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Wellbeing Digital Sciences Inc?
La capitalización bursátil actual de Wellbeing Digital Sciences Inc es $0
